Hepatitis C Virus
Beyond our core therapeutic areas, our researchers study a diverse set of diseases with high unmet needs where we believe great progress for patients is possible.
Our teams are advancing the research and development for diseases that share one commonality — we believe that innovation will lead to new discoveries. Areas of interest include Hepatitis C, HIV, COVID-19, pulmonology, endocrinology, gastrointestinal diseases, and therapeutic neurotoxins.
Our scientific talent and experience are as diverse as the diseases we study. Together, we work around the globe to incubate and advance strategies to help bring medicines and solutions to adults and children in need.
We're leveraging our global expertise, innovative technologies, and collaborative approach to find answers across a diverse set of research interests. Learn how we are working to improve the quality of life for patients in the following areas:
Our infectious disease work includes antibacterial and antiviral programs.
We have research programs investigating idiopathic pulmonary fibrosis (IPF) and cystic fibrosis. In cystic fibrosis, we are exploring approaches that aim to restore a defected protein into its natural state. In pulmonary fibrosis, we are exploring agents to halt and potentially reverse lung fibrosis.
We focus on conditions linked to hormonal disorders, such as hypothyroidism, hyperparathyroidism, and women's health conditions, such as heavy menstrual bleeding due to uterine fibroids in pre-menopausal women.
We're investigating ways to expand the application of toxins as a medical therapy to reduce the instance of atrial fibrillation following cardiac surgery, as well as a therapy for overactive bladder and interstitial cystitis and bladder pain syndrome.
Gastrointestinal tract disorders
We are exploring new ways to address diseases of the gastrointestinal tract not related to autoimmune disorders, including pancreatic enzyme replacement therapy and therapies for irritable bowel syndrome with constipation (IBS-C). In each of these, we are also exploring ways to bring therapies to the pediatric population.
What unique perspective can you bring to the frontier of medicine? Find your fit on our team of innovators and help make a difference for patients in need.
The product-specific site Internet site that you have requested is intended for the residents of a particular country or countries, as noted on that site. As a result, the site may contain information on pharmaceuticals that are not approved in other countries or region. If you are a resident of a country other than those to which the site is directed, please return to AbbVie.com or contact your local AbbVie affiliate to obtain the appropriate product information for your country of residence. The Internet site that you have requested may not be optimized to your screen size. Do you wish to continue to this product-specific site?